Henry Schein Company Insiders
HSIC Stock | USD 74.18 0.40 0.54% |
Henry Schein's insiders are aggressively selling. The analysis of insiders' sentiment of trading Henry Schein stock suggests that all insiders are panicking at this time. Henry Schein employs about 25 K people. The company is managed by 42 executives with a total tenure of roughly 485 years, averaging almost 11.0 years of service per executive, having 595.24 employees per reported executive.
Lonnie Shoff CEO President and CEO of Global Animal Health and Strategic Partnerships Group |
James Breslawski CEO President, Executive Director and CEO of Global Dental Group |
Henry Schein's Insider Buying Vs Selling
0
Selling | Buying |
Latest Trades
2023-12-26 | Stanley M Bergman | Disposed 13962 @ 75.14 | View | ||
2023-12-21 | Bradford C Connett | Disposed 11238 @ 74.02 | View | ||
2023-06-12 | David B Brous Jr | Disposed 11157 @ 74.86 | View | ||
2023-06-02 | James P Breslawski | Disposed 24234 @ 74.29 | View | ||
2023-05-24 | Michael S Ettinger | Disposed 14881 @ 75.12 | View | ||
2023-05-19 | Mark E Mlotek | Disposed 24747 @ 76.68 | View |
Monitoring Henry Schein's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Henry |
Henry Schein's Workforce Through the Years
Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Henry Schein's future performance. Based on our forecasts, it is anticipated that Henry will maintain a workforce of about 25000 employees by April 2024.Henry Schein's latest congressional trading
Congressional trading in companies like Henry Schein, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in Henry Schein by those in governmental positions are based on the same information available to the general public.
2022-01-06 | Senator Susan M. Collins | Acquired $15K to $50K | Verify | ||
2021-02-26 | Representative Michael T. McCaul | Acquired Under $15K | Verify | ||
2021-02-16 | Representative Peter Meijer | Disposed $15K to $50K | Verify | ||
2020-08-07 | Representative Lois Frankel | Disposed Under $15K | Verify | ||
2017-12-06 | Representative Thomas Suozzi | Disposed $15K to $50K | Verify | ||
2014-07-23 | Senator Susan M Collins | Acquired Under $15K | Verify |
Henry Schein Management Team Effectiveness
The company has return on total asset (ROA) of 0.0453 % which means that it generated a profit of $0.0453 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0888 %, meaning that it created $0.0888 on every $100 dollars invested by stockholders. Henry Schein's management efficiency ratios could be used to measure how well Henry Schein manages its routine affairs as well as how well it operates its assets and liabilities. As of March 19, 2024, Return On Capital Employed is expected to decline to 0.10. In addition to that, Return On Assets is expected to decline to 0.04. At present, Henry Schein's Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 219.4 M, whereas Total Current Assets are forecasted to decline to about 2.4 B.The current year's Common Stock Shares Outstanding is expected to grow to about 200.7 M, whereas Net Income Applicable To Common Shares is forecasted to decline to about 375.2 M.
Henry Schein Workforce Comparison
Henry Schein is one of the top stocks in number of employees category among related companies. The total workforce of Health Care industry is currently estimated at about 47,591. Henry Schein totals roughly 25,000 in number of employees claiming about 53% of equities under Health Care industry.
Henry Schein Profit Margins
The company has Profit Margin (PM) of 0.03 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.01 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.01.Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
---|---|---|---|---|---|---|---|---|---|
Gross Profit Margin | 0.32 | 0.35 |
|
| |||||
Net Profit Margin | 0.026 | 0.0383 |
|
| |||||
Operating Profit Margin | 0.0454 | 0.0532 |
|
| |||||
Pretax Profit Margin | 0.041 | 0.0513 |
|
| |||||
Return On Assets | 0.0424 | 0.0563 |
|
| |||||
Return On Equity | 0.088 | 0.14 |
|
|
Henry Schein Insider Trading History
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Henry Schein insiders, such as employees or executives, is commonly permitted as long as it does not rely on Henry Schein's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Henry Schein insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Buy/Sell Ratio | # Purchases Trades | # Sales Trades | Total Shares Purchased | Total Shares Sold | |
---|---|---|---|---|---|
2024-03-01 | 1.0526 | 20 | 19 | 268,440 | 32,300 |
2023-03-01 | 0.6522 | 30 | 46 | 255,693 | 346,178 |
2022-12-01 | 0.1 | 1 | 10 | 336.00 | 118,938 |
2022-09-01 | 0.3333 | 1 | 3 | 399.00 | 1,512 |
2022-06-01 | 0.1429 | 2 | 14 | 2,497 | 70,225 |
2022-03-01 | 0.6604 | 35 | 53 | 309,448 | 240,156 |
2021-12-01 | 0.1818 | 2 | 11 | 688.00 | 51,102 |
2021-09-01 | 0.2222 | 2 | 9 | 688.00 | 45,603 |
2021-06-01 | 0.1875 | 3 | 16 | 2,904 | 88,701 |
2021-03-01 | 1.2759 | 37 | 29 | 517,773 | 140,906 |
2020-12-01 | 0.2 | 1 | 5 | 442.00 | 80,000 |
2020-09-01 | 0.125 | 1 | 8 | 423.00 | 67,985 |
2020-06-01 | 0.1429 | 1 | 7 | 419.00 | 30,169 |
2020-03-01 | 0.5625 | 18 | 32 | 208,315 | 122,692 |
2019-12-01 | 0.0667 | 1 | 15 | 437.00 | 146,478 |
2019-09-01 | 0.5 | 2 | 4 | 105,500 | 8,283 |
2019-06-01 | 0.0833 | 1 | 12 | 353.00 | 83,815 |
2019-03-01 | 0.5758 | 19 | 33 | 235,113 | 120,302 |
2018-12-01 | 0.0588 | 1 | 17 | 263.00 | 140,831 |
2018-09-01 | 0.2 | 1 | 5 | 241.00 | 29,063 |
2018-06-01 | 0.5 | 3 | 6 | 5,229 | 16,691 |
2018-03-01 | 0.9667 | 29 | 30 | 250,780 | 137,809 |
2017-12-01 | 1.0 | 3 | 3 | 6,292 | 11,822 |
2017-09-01 | 2.0 | 2 | 1 | 423.00 | 2,126 |
2017-06-01 | 1.0 | 2 | 2 | 200.00 | 19,916 |
2017-03-01 | 0.7313 | 49 | 67 | 226,368 | 285,556 |
2016-12-01 | 0.4615 | 6 | 13 | 6,727 | 67,979 |
2016-09-01 | 0.2 | 2 | 10 | 193.00 | 16,537 |
2016-06-01 | 0.4706 | 8 | 17 | 53,272 | 66,160 |
2016-03-01 | 0.4235 | 36 | 85 | 168,346 | 246,236 |
2015-12-01 | 0.2727 | 9 | 33 | 27,581 | 139,801 |
2015-09-01 | 0.7143 | 5 | 7 | 4,166 | 17,771 |
2015-06-01 | 0.5 | 5 | 10 | 575.00 | 6,212 |
2015-03-01 | 0.7042 | 50 | 71 | 200,934 | 269,705 |
2014-12-01 | 0.4242 | 14 | 33 | 73,289 | 220,904 |
2014-09-01 | 0.6154 | 8 | 13 | 30,037 | 64,735 |
2014-06-01 | 0.6667 | 12 | 18 | 23,206 | 73,671 |
2014-03-01 | 0.9205 | 81 | 88 | 433,403 | 546,603 |
2013-12-01 | 0.3137 | 16 | 51 | 239,890 | 575,110 |
2013-09-01 | 0.1667 | 4 | 24 | 39,137 | 92,271 |
2013-06-01 | 0.0909 | 2 | 22 | 19,500 | 122,451 |
2013-03-01 | 0.8478 | 39 | 46 | 292,755 | 426,472 |
2012-12-01 | 0.3056 | 11 | 36 | 269,633 | 622,774 |
2012-09-01 | 0.25 | 1 | 4 | 2,405 | 3,680 |
2012-06-01 | 0.1667 | 1 | 6 | 15,000 | 44,269 |
2012-03-01 | 0.8387 | 26 | 31 | 358,881 | 467,961 |
2011-12-01 | 0.5 | 6 | 12 | 127,013 | 94,950 |
2011-06-01 | 0.1429 | 1 | 7 | 20,000 | 9,620 |
2011-03-01 | 0.5128 | 20 | 39 | 244,990 | 346,295 |
2010-12-01 | 0.3529 | 6 | 17 | 48,451 | 100,210 |
2010-09-01 | 0.3 | 3 | 10 | 45,905 | 93,616 |
2010-03-01 | 0.6 | 15 | 25 | 139,318 | 132,642 |
2009-12-01 | 0.3333 | 1 | 3 | 10,000 | 26,000 |
2009-06-01 | 0.5 | 3 | 6 | 50,000 | 112,235 |
2009-03-01 | 2.7143 | 19 | 7 | 150,077 | 20,683 |
2008-09-01 | 0.4 | 2 | 5 | 28,500 | 102,395 |
2008-06-01 | 0.8 | 4 | 5 | 20,619 | 520.00 |
2008-03-01 | 0.6 | 24 | 40 | 291,937 | 78,050 |
2007-12-01 | 0.12 | 3 | 25 | 26,975 | 53,950 |
2007-09-01 | 0.1667 | 1 | 6 | 28.00 | 1,933 |
2007-06-01 | 0.2 | 7 | 35 | 61,386 | 248,628 |
2007-03-01 | 0.963 | 26 | 27 | 277,272 | 154,198 |
2006-12-01 | 0.1282 | 5 | 39 | 91,974 | 173,922 |
2006-06-01 | 0.2381 | 5 | 21 | 50,395 | 104,288 |
2006-03-01 | 0.1231 | 24 | 195 | 256,322 | 119,174 |
2005-12-01 | 2.0455 | 45 | 22 | 92,164 | 144,121 |
2005-09-01 | 0.75 | 3 | 4 | 94,363 | 20,531 |
2005-06-01 | 0.1231 | 8 | 65 | 59,878 | 120,321 |
2005-03-01 | 2.0 | 12 | 6 | 258,783 | 54,466 |
2004-12-01 | 0.2778 | 5 | 18 | 9,859 | 15,330 |
2004-09-01 | 0.1111 | 1 | 9 | 14,800 | 29,600 |
2004-06-01 | 1.0 | 2 | 2 | 20,500 | 35,000 |
2004-03-01 | 0.1828 | 17 | 93 | 218,860 | 149,320 |
2003-12-01 | 0.2593 | 7 | 27 | 18,104 | 144,187 |
Henry Schein Notable Stakeholders
A Henry Schein stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Henry Schein often face trade-offs trying to please all of them. Henry Schein's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Henry Schein's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Lonnie Shoff | President and CEO of Global Animal Health and Strategic Partnerships Group | Profile | |
James Breslawski | President, Executive Director and CEO of Global Dental Group | Profile | |
Jonathan Koch | Senior Vice President and CEO, Global Dental Group | Profile | |
Karen Prange | Executive Vice President; CEO of Global Animal Health, Medical and Dental Surgical Group | Profile | |
Stanley Bergman | Executive Chairman and CEO | Profile | |
Michael Ettinger | Senior Vice President - Corporate and Legal Affairs, Secretary | Profile | |
David McKinley | President Medical Group | Profile | |
Paul Rose | Senior Vice President Global Supply Chain | Profile | |
Brad Connett | President - Henry Schein'sU.S. Medical Group | Profile | |
Lorelei McGlynn | Senior Vice President - Global Human Resources and Financial Operations | Profile | |
Leonard David | Chief Compliance Officer, Senior Vice President | Profile | |
James Harding | CTO, Senior Vice President | Profile | |
Bob Minowitz | President International Dental Group | Profile | |
Peter McCarthy | President - Global Animal Health Group | Profile | |
Bridget Ross | President of Global Medical Group | Profile | |
Christopher Pendergast | Senior Vice President CTO | Profile | |
Walter Siegel | Senior Vice President General Counsel | Profile | |
Carolynne Borders | Vice President - Investor Relations | Profile | |
Michael Racioppi | Senior Vice President Chief Merchandising Officer | Profile | |
Ronald South | Senior CFO | Profile | |
Norman Matthews | Independent Director | Profile | |
Philip Laskawy | Lead Independent Director | Profile | |
Steven Paladino | CFO, Executive VP and Executive Director | Profile | |
Barry Alperin | Independent Director | Profile | |
Shira Goodman | Independent Director | Profile | |
Bradley Sheares | Independent Director | Profile | |
Paul Brons | Independent Director | Profile | |
Gerald Benjamin | Chief Admin. Officer, Executive VP and Director | Profile | |
Dianne Rekow | Director | Profile | |
Anne Margulies | Independent Director | Profile | |
Mark Mlotek | Chief Strategic Officer, Executive VP and Director | Profile | |
Kurt Kuehn | Independent Director | Profile | |
Elizabeth Rekow | Independent Director | Profile | |
Joseph Herring | Independent Director | Profile | |
Donald Kabat | Independent Director | Profile | |
Lawrence Bacow | Director | Profile | |
Louis Sullivan | Independent Director | Profile | |
Carol Raphael | Independent Director | Profile | |
Stanley Komaroff | Sr. Advisor | Profile | |
Graham Stanley | VP Officer | Profile | |
Olga Timoshkina | Chief Finance | Profile | |
Bradford Connett | Chief Group | Profile |
About Henry Schein Management Performance
The success or failure of an entity such as Henry Schein often depends on how effective the management is. Henry Schein management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Henry management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Henry management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last Reported | Projected for 2024 | ||
Return On Capital Employed | 0.11 | 0.10 | |
Return On Assets | 0.06 | 0.04 | |
Return On Equity | 0.14 | 0.09 |
The data published in Henry Schein's official financial statements usually reflect Henry Schein's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Henry Schein. For example, before you start analyzing numbers published by Henry accountants, it's critical to develop an understanding of what Henry Schein's liquidity, profitability, and earnings quality are in the context of the Health Care Providers & Services space in which it operates.
Please note, the presentation of Henry Schein's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Henry Schein's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Henry Schein's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Henry Schein. Please utilize our Beneish M Score to check the likelihood of Henry Schein's management manipulating its earnings.
Henry Schein Workforce Analysis
Traditionally, organizations such as Henry Schein use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Henry Schein within its industry.Henry Schein Manpower Efficiency
Return on Henry Schein Manpower
Revenue Per Employee | 493.6K | |
Revenue Per Executive | 293.8M | |
Net Income Per Employee | 16.6K | |
Net Income Per Executive | 9.9M | |
Working Capital Per Employee | 72.2K | |
Working Capital Per Executive | 43M |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Henry Schein. Also, note that the market value of any Company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. For information on how to trade Henry Stock refer to our How to Trade Henry Stock guide.You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Complementary Tools for Henry Stock analysis
When running Henry Schein's price analysis, check to measure Henry Schein's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Henry Schein is operating at the current time. Most of Henry Schein's value examination focuses on studying past and present price action to predict the probability of Henry Schein's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Henry Schein's price. Additionally, you may evaluate how the addition of Henry Schein to your portfolios can decrease your overall portfolio volatility.
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |
Is Henry Schein's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Henry Schein. If investors know Henry will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Henry Schein listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.62) | Earnings Share 3.16 | Revenue Per Share 94.466 | Quarterly Revenue Growth (0.10) | Return On Assets 0.0453 |
The market value of Henry Schein is measured differently than its book value, which is the value of Henry that is recorded on the company's balance sheet. Investors also form their own opinion of Henry Schein's value that differs from its market value or its book value, called intrinsic value, which is Henry Schein's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Henry Schein's market value can be influenced by many factors that don't directly affect Henry Schein's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Henry Schein's value and its price as these two are different measures arrived at by different means. Investors typically determine if Henry Schein is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Henry Schein's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.